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ABSTRACT
Mutations in the Werner gene promote the segmen-
tal progeroid Werner syndrome (WS) with increased
genomic instability and cancer. The Werner gene
encodes a DNA helicase (WRN) that can engage in
direct protein–protein interactions with DHX9, also
known as RNA helicase A or nuclear DNA helicase II,
which represents an essential enzyme involved in
transcription and DNA repair. By using several syn-
thetic nucleic acid substrates we demonstrate that
WRN preferably unwinds RNA-containing Okazaki
fragment-like substrates suggesting a role in
lagging strand maturation of DNA replication. In
contrast, DHX9 preferably unwinds RNA–RNA and
RNA–DNA substrates, but fails to unwind Okazaki
fragment-like hybrids. We further show that the pref-
erential unwinding of RNA-containing substrates by
WRN is stimulated by DHX9 in vitro, both on Okazaki
fragment-like hybrids and on RNA-containing
‘chicken-foot’ structures. Collectively, our results
suggest that WRN and DHX9 may also cooperate
in vivo, e.g. at ongoing and stalled replication
forks. In the latter case, the cooperation between
both helicases may serve to form and to dissolve
Holliday junction-like intermediates of regressed
replication forks.
INTRODUCTION
The progeroid human disease Werner’s syndrome (WS) is
a widely used model for studying molecular aspects of
human aging [for recent reviews see e.g. (1,2)]. WS repre-
sents a monogenic disease with mutations in the WRN
gene, which encodes a member of the superfamily 2
(SF2) subgroup of RecQ helicases with 30-50 unwinding
and a unique 30-50-exonuclease activity [see e.g. (3)].
Initially, the recQ gene product was identiﬁed in bacteria
as an enzyme presumed to be involved in recombination
repair and that, among others, clears replication block-
ades from stalled or collapsed replication forks (4,5).
Similarly, mutants in the SGS1 gene, the only RecQ
helicase in Saccharomyces cerevisiae, display replisome in-
stability and replication fork collapses (6). In addition,
Sgs1 helicase is necessary to maintain the DNA polymer-
ases a and " at stalled replication forks (7). Cells from
WS patients show a retarded progression through the
S phase of the cell cycle (8,9), and in normally
proliferating primary human ﬁbroblast, about 60% of
replication foci contain WRN (10,11). Together, this indi-
cates an important but non-essential role in unperturbed
DNA replication. Yet, whenever a replication fork comes
to a halt, WRN is preferentially attracted to these sites
(12). In line with this, WRN syndrome cells are hypersen-
sitive to drugs that block ongoing replication forks, such
as 4-nitroquinoline-N-oxide (4-NQO) or camptothecin
(13,14). Apparently, WS cells display defects in the
resolution of homologous recombination intermediates,
particularly Holliday junctions (HJs) and ‘chicken-foot’
structures that result from collapsed replication forks
(15,16).
Recently we have demonstrated that WRN functionally
cooperates with DHX9 (17) [unoﬃcial HUGO nomencla-
ture used; other names are nuclear DNA helicase II (NDH
II) or RNA helicase A (RHA)], another member of the
SF2 family helicases with a 30-50 directionality (18). DHX9
coprecipitates with WRN and stimulates its 30-50 exonucle-
ase activity, whereas DNA unwinding is inhibited (17).
Moreover, a fraction of WRN and DHX9 colocalizes at
centrosomes during interphase (19), and both enzymes
interact with the mediator of homologous recombination
BRCA1 (20,21). In addition, WRN and DHX9 interact
with DNA-dependent protein kinase (22,23) and
Ku70/Ku80 (24,25) that together form a checkpoint
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also bind to the sliding clamp for replicative DNA poly-
merases PCNA (26,27), while until now only WRN has
been shown to interact with DNA polymerase d (28), ﬂap
endonuclease I (FEN-1) (29), and the single-strand
DNA-binding protein RPA (30), all of which are compo-
nents of the Okazaki fragment maturation apparatus [see
e.g. (31)]. Collectively, these ﬁndings suggest a joint role
for both enzymes in lagging strand maturation as well as
in the rescue of stalled replication forks. Since every
Okazaki fragment starts with a short piece of RNA, typ-
ically 8–12nt in length (32), we tried to mimic this
situation by designing appropriate template-primers
and exploring the inﬂuence of 50-RNAs on the unwinding
kinetics of WRN. Using this approach we could show that
WRN preferentially unwinds Okazaki fragment-like
hybrids in a reaction that was stimulated by DHX9.
Although WRN has been well characterized
enzymologically, this new function further elucidates the
role of WRN in DNA replication and lagging strand mat-
uration. Based on our data we also suggest a model for the
formation and dissolution of chicken-foot structures by
the joint action of WRN and DHX9 that may facilitate
a recombinational bypass of DNA damages.
MATERIALS AND METHODS
Expression and puriﬁcation of recombinant proteins
Recombinant human DHX9 and WRN proteins were
produced and puriﬁed from baculovirus-infected
High-Five
TM cells as described previously (17).
Radioactive labeling and annealing
50-end labeling was achieved by T4 polynucleotide kinase
from Fermentas (St. Leon-Rot, Germany) and g-
33P-ATP
(5000Ci/mmol) (Hartmann Analytical, Braunschweig,
Germany) in ‘forward’ reaction buﬀer (80mM Tris–HCl,
pH 7.4, 10mM MgCl2 and 5mM DTT) from Fermentas.
Unincorporated material was removed from the labeled
oligonucleotide using Microspin TM-25 columns from
GE (Amhearst, UK), and, if necessary, by a successive
run through an RNase-free Micro Bio-Spin P-30 column
(Bio-Rad, Munich, Germany), equilibrated with 10mM
Tris-buﬀer, pH 8.0.
Helicase substrates
Highly puriﬁed oligonucleotides (listed in Table 1) were
purchased from Purimex (Grebenstein, Germany).
Oligonucleotides were synthesized in a 1000nmol scale
and subsequently puriﬁed either by polyacrylamide elec-
trophoresis (RNA) or by HPLC (DNA). Oligonucleotide
primers were designed to form a series of DNA structures
as follows: Simple hybrids: 1–10pmol/ml M1, M2, R1, R2,
R1D, R4D and R8D (Table 1) were 50-labeled with
[g-
33P]ATP and annealed to oligonucleotides containing
a complementary region of 17nt and a 30-overhang. HJs
were prepared by mixing the labeled oligonucleotide
with a 2-fold molar excess of the complementary un-
labeled strands. Samples were heated to 100 C for 5min
followed by incubation at 25 C for 3–4h or cooling down
overnight to room temperature.
Helicase assays
The helicase assays contained the
33P-labeled substrate in
10ml of 20mM Tris–HCl, pH 7.5, 3.5mM MgCl2, 3.5mM
ATP, 0.1mg/ml BSA, 5mM dithiothreitol and 10%
glycerol. Reactions were initiated by the addition of
enzyme; incubation was between 0 and 30min at 37 C.
DNA unwinding was terminated by rapid cooling on ice
and by the addition of 3.5ml stop buﬀer (0.2% SDS,
50mM EDTA, 0.1% bromophenol blue, 0.1% xylene
cyanol, 40% glycerol) along with the addition of 10-fold
excess of unlabeled oligonucleotide to prevent reannealing
of the unwound strand. The products were separated
by electrophoresis through 10–12 % non-denaturing poly-
acrylamide gels at 4 C, and visualized using a
PhosphorImager and quantiﬁed using the ImageQuant
software (GE Healthcare). WRN and DHX9 helicase
were inactivated using 50mM N-ethylmaleimide that, by
forming irreversible cysteine bonds, knocked-down
helicase activities (33). The rate of unwinding was
calculated as (ssDNA/total DNA) nM substrate/mM
enzyme/time. The percentage of unwound substrate was
determined as [(% unwinding)=100 (P/(S+P)], where
P is the product and S is the residual substrate as obtained
from the PhosphorImager (34,35). The values of P and S
were corrected after subtracting background values as
obtained from controls with no enzyme. Unwinding
rates were determined using a linear regression through
the initial linear part of the time course.
Table 1. Oligonucleotides used in this study
Name of the oligonucleotide Length Sequence
DNA M1 17 50CCTGCAGGCATGCAAGC30
DNA M2 34 50GCTTGCATGCCTGCAGGCCAGCCTCAATCTCATC30
DNA M3 34 50CTACTCTAACTCCGACCGCTTGCATGCCTGCAGG30
DNA M4 34 50ATCCTCTCTAGAGTCGACCTGCAGGCATGCAAGC30
DNA-S1 34 50GATGAGATTGAGGCTGGGAAAAGTTACTGTAGCC30
DNA-S2 34 50GGCTACAGTAACTTTTCTCGACTCTAGAGAGGAT30
RNA R1 17 50CCUGCAGGCAUGCAAGC30
RNA R2 34 50GCUUGCAUGCCUGCAGGCCAGCCUCAAUCACAUC30
RNA–DNA R8D 17 50rCrCrUrGrCrArGrGdCdAdTdGdCdAdAdGdC30
RNA–DNA R4D 17 50rCrCrUrGrdCdAdGdGdCdAdTdGdCdAdAdGdC30
RNA–DNA R1D 17 50rCdCdUdGdCdAdGdGdCdAdTdGdCdAdAdGdC30
RNA–DNA R8M4 34 50rArUrCrCrUrCrUrCdTdAdGdAdGdTdCdGdAdC
dCdTdGdCdAdGdGdCdAdTdGdCdAdAdGdC30
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DNA-binding reactions were performed in 10ml2 0 m M
triethanolamine–HCl, pH 7.5,2mM MgCl2, with or
without 1mM ATPgS as indicated, 0.1mg/ml BSA,
1mM dithiothreitol, DNA and protein concentrations as
given. Following incubation at room temperature for
30min, the reaction was stopped with loading buﬀer
(6% Ficoll, 0.1% bromophenol blue, 0.1% xylene
cyanol, 40% glycerol) and the products were separated
by electrophoresis through 4% nondenaturing polyacryl-
amide gels at 4 C for 2h. Gels were dried, scanned and
quantiﬁed as described above. The percentage of binding
was calculated as the ratio between bound and unbound
radiolabeled substrate. The Kd values were estimated from
Scatchard analyses.
RESULTS
Both WRN and DHX9 preferably unwind RNA-
containing heteroduplexes
We constructed several homo- and heteroduplexes with
DNA and RNA (Table 1) and determined the activities
of WRN and DHX9 in parallel. To avoid diﬀerent GC
contents and a potential formation of stable secondary
structures within one strand we always used the same
sequence for DNA and RNA substrates in direct
Figure 1. Unwinding of short fully hybridized strands. Time course for the unwinding of M2:M1 by WRN (A) or DHX9 (B), unwinding of R2:R1
by WRN (C) and DHX9 (D), and melting of M2:R1 by WRN (E) or DHX9 (F) 28nM of WRN or of DHX9 and 1nM of substrates were used for
each experiment. Triangle represents heat-denatured DNA substrate control, NE no enzyme. The positions of the substrates and reaction products
are indicated; double lines depict RNA containing strands. The asterisk represents the 50-labeled nucleotide. Quantiﬁcations of duplex unwinding by
WRN (G) and DHX9 (H) are also depicted. Error bars indicate SD as derived from three independent experiments.
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oligonucleotide was used to mask out a potential
reannealing of the unwound strand. Both enzymes
unwound DNA:DNA duplexes with unwinding rates of
about 0.24 and 0.08nM (17-mer) min
 1mM
 1 enzyme
for WRN and DHX9, respectively (Figure 1A and B).
WRN unwound an RNA:RNA 17-mer duplex with a
17-mer 30 single-strand extension extremely poorly
(Figure 1C), whereas DHX9 melted RNA:RNA strands
with a rate of 0.72nM min
 1mM
 1 enzyme (Figure 1D),
which conﬁrms and extends earlier ﬁndings (36,37).
DHX9 unwound the double-stranded (ds) RNA substrate
R2:R1 within 5min to about 80% and the DNA:RNA
hybrid, M2:R1, to 72%. If one of the two strands con-
sisted of DNA, DHX9 was slightly slower than WRN
yielding unwinding rates of 0.74 and 0.86nM (17-mer)
min
 1mM
 1, respectively (Figure 1E and F).
Quantiﬁcations of duplex unwinding by WRN and
DHX9 are depicted in Figure 1G and H, respectively. In
summary, both enzymes unwound RNA-containing
heteroduplexes considerably faster than dsDNA.
WRN helicase preferably unwinds Okazaki
fragment-like structures
Since WRN acted best on RNA–DNA hybrids, we next
looked at Okazaki fragment-like substrates, consisting of a
mixed 17-mer with an 8-mer of RNA at the 50-end followed
by a 9-mer of DNA that was hybridized to a 34-mer DNA
template (R8D:M2, Table 1). Unexpectedly, DHX9
unwound R8D:M2 poorly (Figure 2A, lanes 8–12), even
at a lower rate than the corresponding DNA:DNA sub-
strate (Figure 1B), and about 10-fold slower than the cor-
responding RNA:DNA hybrid (Figure 1D). In striking
contrast, 28nM WRN dissociated half of the R8D:M2
construct in 1.5min (Figure 2A, lanes 3–7), yielding an un-
winding rate of  1.5nM (17-mer)min
 1mM
 1 enzyme.
Hence, WRN displaced Okazaki fragment-like primers
6.2- and still 1.8-fold faster than the comparable
DNA:DNA or RNA:DNA constructs (see also
Supplementary Figure S1A).
Next we examined the size of RNA that stimulated un-
winding by WRN. To this end we designed 17-mer oligo-
nucleotides with 50-ends consisting of four (R4D) and only
one (R1D) ribonucleotide and measured the eﬃciency of
unwinding. Compared to R8D:M2, DHX9 unwound
R4D:M2 and R1D:M2 even slower (Figure 2B and C,
lanes 8–12). On the other hand, WRN displaced R4D
and R1D from DNA in 3min (Figure 2B and C,
lanes3–7), which was 2-fold slower than the unwinding
of R8D but similar to the unwinding of a 17-mer RNA
strand. 28nM WRN melted R8D:M2 completely within
3min while R4D:M2 and R1D:M2 became unwound to
60 and 49%, respectively (Figure 2D).
Therefore, apparently only one ribonucleotide at the
50-end suﬃced to mark the corresponding oligonucleotide
for a rapid unwinding by WRN. On the ﬁrst glance this
may indicate that WRN recognizes the transition from
RNA to DNA on one of the two strands. Alternatively,
50-RNA–DNA hybrids or their assumed A-conformation
may better ﬁt into the active site of WRN and thereby
facilitate unwinding. This scenario would also explain
why full hybrids were better unwound than DNA
double-strands.
DHX9 stimulates WRN-catalyzed unwinding of Okazaki
fragment-like structures
Since DHX9 and WRN copuriﬁed and inﬂuenced each
other’s activities (17) we looked at possible cooperative
eﬀects on Okazaki fragment-like substrates. Unwinding
of R8D:M2 by WRN (Figure 3A, lanes 3 and 6) was
stimulated by DHX9 (Figure 3A, lanes 5 and 8), in a
time-dependent manner, while 14nM DHX9 alone
did not unwind the same template-primer (Figure 3A,
Figure 2. Unwinding of Okazaki fragment-like structures. (A) Time
course of unwinding of R8D:M2. (B) Time course of unwinding of
R4D:M2. (C) Time course of unwinding of R1D:M2. Unwinding of
either construct by 28nM WRN (left) or DHX9 (right) and 1nM
of substrate is shown in a 10-min time scale. Triangle represents,
heat-denatured control; NE, no enzyme. 8R, 4R and 1R indicate the
numbers of ribonucleotides at the 50 ends. (D) Quantiﬁcation of un-
winding of R8D (diamonds), R4D (squares) and R1D (triangles) by
WRN. Error bars indicate SD as derived from three independent
experiments.
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WRN on simple DNA:RNA (Figure 3B, lanes 3–8) or
DNA:DNA substrates (Figure 3C, lanes 3–8) neither did
it with RNA:RNA hybrids (data not shown). Taken
together, DHX9 stimulated WRN on Okazaki
fragment-like substrates about 2-fold (Figure 3D). Since
this had not been observed with the RNA containing
substrate M2:R1 (Figure 3B), we conclude that the stimu-
lation was due to protein–protein interactions rather
than to the trapping of melted pieces of RNA by
DHX9. To decide whether this enhancement was due to
a DHX9-mediated stimulation of WRN or, alternatively,
due to the stimulation of DHX9 by WRN, we treated
both helicases with 50mM N-ethylmaleimide for 10min.
This procedure inactivated the unwinding activity of
both enzymes (Figure 3E, lanes 3–5). However,
NEM-inactivation could be rescued by supplementing
the inactivation buﬀer with 100mM DTT (Figure 3E,
lanes 6–8). An amount of 14nM each of NEM-treated
WRN (w) and untreated DHX9 (D) did not unwind
R8D:M2 (Figure 3F, lane 6). Instead, addition of 14nM
of poisoned DHX9 (d) stimulated WRN (W) as eﬃciently
as untreated DHX9 did (cf. Figure 3E, lane 8 with
Figure 3F, lane 7). This indicates that DHX9 exerts a
stimulatory eﬀect onto WRN independent of its helicase
activity. Because of its high aﬃnity for dsRNA, DHX9
should be well suited to resolve any potential RNA sec-
ondary structures at the 50-end of an Okazaki fragment,
which otherwise may prevent cleavage by FEN1 and/or
unwinding by WRN (38).
WRN prefers binding to Okazaki fragments and other
DNA–RNA substrates
To further explore the mode of binding of WRN to various
substrates we performed gel shift assays. In the absence
of ATP, WRN bound DNA–DNA (M2:M1) better than
DNA–RNA (M2:R1) with Kd values of about 1 10
 7M
and 5 10
 7M, respectively (Figure 4A). Surprisingly,
there was little binding to the Okazaki fragment-like sub-
strate R8D:M2 that only became detectable at the highest
amount of the enzyme giving rise to a Kd of about
4 10
 6M (Figure 4A). But in the presence of the
Figure 3. DHX9 stimulates the unwinding of Okazaki fragment-like structures by WRN. (A) Unwinding of 1nM R8D:M2 catalyzed by 14nM
WRN (lanes 3 and 6), 14nM DHX9 (lanes 4 and 7) or 14nM each of WRN and DHX9 (lanes 5 and 8) after 3min (lanes 3–5) or 5min (lanes 6–8)
incubation at 37 C. (B) The same experiment as shown in panel A except that 1nM R1:M2 was used as substrate. (C) The same experiment as shown
in panel A except that 1nM M1:M2 was used. (D) Quantiﬁcation of the unwinding of R8D:M2 by 14nM WRN in the presence of 14nM DHX9.
(E) Unwinding of 1nM R8D:M2 catalyzed by 21nM poisoned WRN (w, lane 3), 21nM poisoned DHX9 (d, lane 4), and 21nM each of
NEM-poisoned WRN and DHX9 (wd, lane 5). Poisoning could be rescued by adding 0.1M DTT together with NEM (lanes 6–8).
(F) Unwinding of 1nM R8D:M2 catalyzed by 21nM WRN (lane 3), DHX9 (lane 4), WRN plus DHX9 (lane 5), NEM-poisoned WRN plus
untreated DHX9 (w, lane 6), NEM-poisoned DHX9 plus untreated WRN (Wd, lane 7), and poisoned WRN plus poisoned DHX9 (wd, lane 8). Error
bars indicate SD as derived from three independent experiments.
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WRN for the DNA–DNA substrate decreased signiﬁcant-
ly, yielding a Kd of about 3 10
 6M (compare Figure 4A
and B), whereas binding to the DNA–RNA substrate
appeared unaﬀected (5 10
 7M) (Figure 4A and B).
Interestingly, in the presence of ATPgS, WRN bound
the Okazaki fragment-like oligonucleotide R8D:M2
much better (Kd=2 10
 7M) than without a nucleotide
cofactor (cf. lanes 3 and 4 in Figure 4A and B). This
behavior is not without precedence. The 50-30 helicase
Pif1, which is also thought to be involved in Okazaki
fragment unwinding, bound forked DNA–DNA and
DNA–RNA substrates equally well in the absence of
any nucleoside triphosphate (39). In the presence of
ATPgS however, i.e. the condition that comes closest to
DNA unwinding, DNA–DNA forks were bound much
tighter than DNA–RNA forks (39). Despite this, Pif1
unwound RNA–DNA forks much better than the corres-
ponding DNA–DNA forks, whereas WRN unwound the
best-bound substrate R8D:M2 with the largest rate. Our
data suggest that ATP stimulates binding of WRN to
R8D:M2 and, as a consequence, its unwinding.
Therefore, ATP may facilitate initial loading of the
enzyme to this substrate and/or stabilize the enzyme sub-
strate complex after loading to stimulate any unwinding.
DHX9 stimulated the unwinding of HJs by WRN helicase
when one strand starts with an RNA piece
All our data strongly suggest that WRN plays a role in
Okazaki fragment maturation. However, WRN is not an
essential enzyme and other enzymes, such as the
50-helicases Pif1 and Dna2, have been suggested to
perform lagging strand maturation after strand displace-
ment synthesis by DNA polymerase delta (32). Also, in
normally proliferating primary human ﬁbroblast, only
60% of replication foci contain WRN (10,11), while
WRN clearly becomes attracted to sites where replication
forks come to a halt, most likely because of an underlying
DNA damage (12). Stalled replication forks may regress
and form HJs and chicken-foot structures (40,41) that,
because of an inevitable involvement of an Okazaki
fragment, must begin with a short piece of RNA on one
of the four strands. To account for this particular situ-
ation, we designed a HJ that started with an 8-nt long
piece of RNA on one strand followed by 24nt of DNA
(Table 1, R8M4:M2:S1:S2). WRN unwound both the
Figure 4. WRN binds to R8D:M2, M2:R1, and M2:M1 in an ATPgS-dependent manner. (A) Substrate (50fmol) was incubated without (NE, lane 1)
and with increasing amounts of WRN (as indicated) in the absence of any nucleotide. (B) The same experiment as shown in panel A, but this time in
the presence of 1mM ATPgS. The radiolabeled DNA species were analyzed on a native 4% PAGE and visualized by PhosphorImaging. The bands
in the slots on top of the gel were also visible in many no enzyme controls and probably represent aggregated substrate.
Figure 5. DHX9 stimulates the WRN-catalyzed branch migration of an RNA-primer containing HJ. (A) WRN-catalyzed (28nM) unwinding of
1nM of the synthetic RNA-primer HJ substrate R8M4:M2*:S1:S2. WRN unwound about half of the substrate within 30min at 37 C (lane 3) while
DHX9 failed to do so (lane 4). With 28nM each of DHX9 and WRN complete unwinding was achieved (lane 5). The reaction products were
resolved on a native 10% polyacrylamide gel and visualized by PhosphorImaging. (B) 60fmol radiolabeled HJ were incubated with the indicated
amounts of WRN and/or DHX9. After 20min preincubation at 37 C in the presence of 1mM ATPgS, the products were separated by electro-
phoresis through a 4% non-denaturing polyacrylamide gel at 4 C and visualized using a PhosphorImager. The bands in the slots on top of the gel
were also visible in the no enzyme control (lane 1) and probably represent aggregated substrate.
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lane 3, and Supplementary Figure S1), whereas DHX9
was not able to unwind either construct (Figure 5A, lane
4, and Supplementary Figure S2). In agreement with the
observed stimulation of unwinding of RNA-containing
pieces by WRN, DHX9 stimulated the unwinding of an
RNA-primer containing HJ by WRN at about stoichio-
metric amounts (Figure 5A, lane 5), but apparently in-
hibited it when the junction consisted only of DNA. On
this substrate an about 2-fold molar excess of WRN was
needed to overcome the inhibitory action of DHX9
(Supplementary Figure S2B). Therefore in the presence
of DHX9, WRN could only resolve HJ when these con-
tained primer RNA on one of the four arms.
The binding of WRN to an RNA-primer containing
HJ was directly determined by gel mobility shift assays
(Figure 5B). An amount of 40–160fmol WRN produced
a signiﬁcant amount of shifted HJ products (Figure 5B,
lanes 2–4), whereas the same amounts of DHX9 did
not bind to the substrate (Figure 5B, lanes 5–7).
Approximately 80% of the RNA-HJ was bound by
160fmol of WRN (Figure 5B, lane 4), with a Kd value of
about 5 10
 8M. Substrate binding of WRN was not
aﬀected by the presence of 160nM DHX9 (Figure 5B, cf.
lanes 2–4 and lanes 8–10). This indicates that DHX9 exerts
its stimulatory eﬀect on the branch migration activity of
WRN by enhancing its catalytic constant (kcat) rather than
by increasing its substrate aﬃnity (Ka).
DISCUSSION
WRN and DHX9 represent a pair of helicases that
copurify, coimmunoprecipitate, and cooperate at a func-
tional level. Earlier, the interaction sites had been mapped
to the N-terminal exonuclease domain of WRN as well as
to the double-strand RNA-binding domain II (dsRBD II)
and the arginine/glycine-rich RGG box of DHX9 that are
situated N- and C-terminally, respectively. In this study,
we observed that both helicases unwound fully hybridized
DNA-strands, but with rather slow rates, whereas
DNA:RNA heteroduplexes were melted considerably
faster than DNA:DNA strands. This is remarkable since
only a few of the currently reported helicases are known to
unwind DNA–RNA hybrids eﬃciently. The eﬀective un-
winding of double-stranded hybrids initially indicated to
us that RNA primers, which mark the beginning of
Okazaki fragments, might be ideal substrates for both
enzymes. This turned out to be true for WRN, since this
helicase unwound 50-R8D9-30 oligonucleotides much faster
than the corresponding DNA:DNA and even RNA:DNA
strands. A successive shortening of the RNA piece from
eight over four to only one nucleotide revealed that a
single ribonucleotide at the 50-end was suﬃcient to stimu-
late the unwinding activity of WRN, although unwinding
became slower when there were fewer RNA nucleotides
at the 50-end. Nevertheless it is noteworthy that a
DNA:DNA construct with a single 50-ribonucleotide at a
17-mer strand became unwound as fast as the correspond-
ing RNA:DNA hybrid. A single 50-ribonucleotide remains
whenever one of the two (potential) mammalian primer
removing enzymes RNase H1 or 2 cleave oﬀ the RNA
primer from an Okazaki fragment [for a recent review
see (42)]. Thus, even one remaining 50-ribonucleotide
suﬃced to direct WRN helicase to Okazaki fragment un-
winding. Here WRN may catalyze melting of the RNase
H-cleaved fragment as a prerequisite for the subsequent
cleavage by the FEN-1 endonuclease, which in turn is ne-
cessary to remove the error-prone DNA primer inserted
by DNA polymerase a (43). Surprisingly, in vitro the
WRN-catalyzed unwinding of Okazaki fragment-like
mixed-hybrids was stimulated by DHX9 indicating that
the latter enzyme may also become loaded into these
sites in vivo. Because DHX9 preferentially removes RNA
duplexes (Figure 1D), it is particularly suited to unwind
RNA containing hairpin structures that in turn may
obstruct cleavage by FEN-1 (41) or digestion by RNase
H (42). In agreement with this view, both DHX9 and
WRN interact with PCNA (26,27) and WRN has been
shown to stimulate both the lagging strand DNA poly-
merase d (28) and the primer-removing endonuclease
FEN-1 (29). Therefore, WRN may play a role in
Okazaki fragment unwinding as suggested earlier [see
e.g. (44)], perhaps together with the also discussed 50-30
helicases Dna2 and Pif1 (45,46).
In addition to the discussed role of DHX9 in Okazaki
fragment unwinding this enzyme seems to aid WRN in
restarting halted replication forks. The melting of the
50-end of the ultimate Okazaki fragment is a prerequisite
for the formation of a chicken-foot structure. At stalled
replication forks DNA polymerase d cannot accomplish
strand displacement synthesis that in term is required for
the loading of the 50-30-helicases Dna2 or Pif1. Thus a
30–50-helicase like WRN is necessary to displace the
50-end of the Okazaki fragment next to the stalled fork.
According to our results DHX9 would stimulate this
reaction and contemporarily prevent secondary structure
formation of the outmost 50 RNA portion (Figure 6, top).
The leading strand must also be unwound, perhaps by
Dna2 or Pif1, or alternatively by the 50–30 helicase
BACH1 (BRCA1 associated C-terminal helicase, also
known as BRIP1 and FancJ), which may become at-
tracted via the WRN- and DHX9-binding protein
BRCA1 (47), and whose activity is required for the
timely progression through S phase of the cell cycle (48).
BACH1 senses and unwinds damages in one of the duplex
strands (49) and therefore might act as the prime candi-
date 50 helicase for chicken-foot formation on damaged
DNA. Also, fork regression either requires positive super-
coiling ahead of the stalled fork and/or the action of BLM
helicase, which interestingly is part of the BRAFT super
complex (50), comprising the BLM complex and the
Franconia anemia complex including BACH1/FancJ
(51). Since the strand annealing activity of DHX9 is
stronger than that of WRN (unpublished observation),
DHX9 may also help to form the RNA-containing HJ
(Figure 6, center). Furthermore, once the regressed fork
becomes resuscitated, e.g. after the underlying DNA
damage has been repaired, DHX9 can stimulate dissol-
ution of the chicken-foot by WRN (Figure 6, bottom).
Hence, similar as and together with WRN, DHX9 may
play a role in the removal of replication blockades.
4728 Nucleic Acids Research, 2010,Vol.38, No. 14Collectively, our ﬁndings strongly suggest cooperative
functions for WRN and DHX9 at both migrating and
stalled replication forks, where they seem to be involved
in the removal of primer RNA-containing Okazaki frag-
ments and the removal of replication hindrances by
stimulating the dissolution and, as suggested here, also
the formation of chicken-foot structures. Therefore, like
WRN, DHX9 may signiﬁcantly contribute to the main-
tenance of genomic stability. However, further investiga-
tions are warranted for a better understanding of the
mechanism(s) involved in processing chicken-foot struc-
tures and intermediates of stalled replication forks.
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